Reimbursement Established for Lung and Liver Transplant in the Netherlands Based on Results from Clinical Trials with XVIVO's Leading Technologies

Author's Avatar
May 12, 2022

GOTHENBURG, SE / ACCESSWIRE / May 12, 2022 / XVIVO Perfusion AB (STO:XVIVO, Financial) (LSE:0RKL, Financial) (FRA:3XV, Financial)